Biologicals and the current obstacles Biologicals are the future of Pharma. With their tremendous potential to address various unmet medical needs, they make up the major part of the pipelines of Pharma companies. However, there are some issues with which pharmaceutical companies developing biologicals continue to struggle. They are difficult to make, and they are hard […]
Updated Bioeconomy strategy for Europe Europe’s Bioeconomy Strategy has been updated in order to accelerate the deployment of a sustainable European bioeconomy. Europe’s 2012 Bioeconomy Strategy focusses on the production of renewable biological resources and their conversion into vital products and bio-energy. The major aim of the strategy is to pave the way to a […]
Over the last 5 years, no less than 63% of all new prescription drug approvals originated at smaller outfits (reported by HBM Partners). The main reason: pharma giants rarely conduct early scientific research anymore. More and more, big pharma companies let the “risky” early development phase over to start-ups to later acquire or license their drugs. […]
GROWTH is an innovative educational project for entrepreneurs which focuses on the development of knowledge and skills for growth. It offers interactive action-oriented teaching and learning about entrepreneurial growth to entrepreneurs. The teaching consists of four educational building blocks (combining online and face-to-face learning): online modules (SPOCs), entrepreneurial labs, simulation games and mix & match […]
Successful startups know that one good project can take months of tinkering and trial and error. We all know that the process and effort are just as important as the result. As Thomas Edison said on his path to inventing the light: “I have not failed. I’ve just found 10,000 ways that won’t work”. 3 […]